Conservative treatment of acute hepatic failure

Zeitschrift fur Gastroenterologie

Volumn 34, Issue 3, 1996, Pages 192-201

  Holstege, A ^a,b   Lock, G ^a   Kollinger M ^a   Scholmerich J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

acute liver failure; cerebral edema; hepatic encephalopathy; liver assist device; liver transplantation

Indexed keywords

PROSTAGLANDIN E2;

BLOOD CLOTTING; BRAIN EDEMA; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOGLYCEMIA; KIDNEY FAILURE; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; REVIEW;

ANIMALS; ARTIFICIAL ORGANS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; PERFUSION; PROGNOSIS; SWINE;

EID: 0029937686     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Gohda E, Tsubouchi H, Nakayama H et al Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-9
2. Minuk GY. Hepatic regeneration in fulminant hepatic failure Can J Gastroenterol 1993; 7: 545-6
3. Faulstich H, Jahn W, Wieland T. Silybin inhibition of amatoxin uptake in the perfused rat liver. Arzneimittelforschung 1980; 30. 452-4
4. Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-98
5. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-5
6. Bernuau J, Benhamou JP. Classifying acute liver failure. Lancet 1993; 342: 252-3
7. O'Grady JG. Management of acute and fulminant hepatitis A. Vaccine 1992; 10: 21-3
8. Saracco G, Rosina F, Brunetto MR et al. Rapidly progressive HBs-Ag-positive hepatitis in Italy. The role of hepatitis delta virus infection J Hepatol 1987; 5: 274-81
9. Lettau LA, McCarthy JG, Smith MH et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contracts N Engl J Med 1987; 12: 1256-62
10. Wright TL, Mamish D, Combs C et at. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339: 952-5
11. Liang TJ, Jeffers L, Reddy RK et al. Fulminant or subfulminant non-A, non-B viral hepatitis, the role of hepatitis C and E viruses. Gastroenterology 1993; 104: 556-62
12. Nanda SK, Yalcinkaya K, Panigrahi AK et al. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994, 42: 133-7
13. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis N Engl J Med 1991; 324: 1705-9
14. Omata M, Ehata T, Yokosuka O, Hosoda K, Oito M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis N Engl J Med 1991; 324: 1699-1704
15. Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105: 1173-8
16. Ede RJ, Williams R. Hepatic encephalopathy and cerebral edema. Semin Liver Dis 1986; 6: 107-18
17. Watanabe A, Shiota T, Tsuji T. Cerebral edema during hepatic encephalopathy in fulminant hepatic failure. J Med 1992; 23. 29-38
18. Munoz SJ. Difficult management problems in fulminant hepatic failure Semin Liver Dis 1993; 13: 395-413
19. Pomier-Layrargues G, Giguere JF, Lavoie J et al. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology 1994; 19. 32-7
20. Williams R, Gimson AES. Intensive liver care and management of acute hepatic failure Dig Dis Sci 1991; 36: 820-6
21. Bullimore D. The role of polyamines in hepatic encephalopathy and cerebral oedema Eur J Gastro Hepatol 1993; 5. 63-7
22. Keays RT, Alexander GJM, Williams R. The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol 1993; 18. 205-9
23. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341 157-8
24. Hanid MA, Davies M, Mellon PJ et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 1980; 21: 866-9
25. Lidofsky SD, Bass NM, Prager MC et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992, 16-7
26. Schafer D, Shaw B Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis 1989; 9: 189-94
27. Munoz S, Robinson M, Northrup B et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1991; 13. 209-12
28. Ede RJ, Gimson AES, Bihari DJ, Williams R. Controlled hyperventilation in the prevention of cerebral edema in fulminant hepatic failure. J Hepatol 1986; 2: 43-51
29. Canalese J, Gimson AES, Davis C et al. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure. Gut 1982; 23: 625-9
30. O'Grady JG, Williams R Acute liver failure. Bailliere's Clin Gastroenterol 1989; 3: 75-89
31. Forbes A, Alexander GJM, O'Grady J et al. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10: 306-10
32. Rolando N, Harvey F, Brahm J et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991; 12: 1-9
33. Rolando N, Harvey F, Brahm J et at. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11: 49-53
34. Rolando N, Gimbson A, Wade J et al. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201
35. Salmeron JM, Tito L, Rimola A et al. Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. J Hepatol 1992; 14: 280-5
36. Wiesner R. The incidence of gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination. Infection 1990; 18 (suppl. 1): 519-21
37. Bihari D, Gimson A, Lindridge J, Williams R. Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J Hepatol 1985a; 1. 405-16
38. Bihari D, Gimson AE, Waterson M, Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med 1985b; 13: 1034-9
39. Wendon JA, Harrison PM, Keays R et al. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 1992; 15 1067-71
40. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-7
41. Muto Y, Nouri-Aria KT, Meager A et al. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure Lancet 1988, 9: 72-4
42. Paramo JA, Rocha E. Hemostasis in advanced liver disease. Semin Thromb Hemost 1993; 19. 184-90
43. Egbring R, Seitz R. Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination. Z Gastroenterol 1990; 28: 104-9
44. Pernambuco JRB, Langley PG, Hughes RD, Izumi S, Williams R. Activation of the fibrinolytic system in patients with fulminant liver failure Hepatology 1993; 18: 1350-6
45. Langley PG, Keays R, Hughes RD et al. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology 1991; 14: 251-6
46. Langley PG, Hughes RD, Forbes A, Keays R, Williams R. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol 1993; 17: 326-31
47. Gazzard BG, Henderson JM, Williams R Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut 1975; 16: 617-20
48. O'Grady JG, Langley PG, Isola LM, Aledort LM, Williams R. Coagulopathy of fulminant hepatic failure. Semin Liver Dis 1986; 6: 159-63
49. Mac Dougall BR, Williams R. H2-receptor antagonist in the prevention of acute upper gastrointestinal hemorrhage in fulminant hepatic failure: a controlled trial. Gastroenterology 1978; 74: 464-5
50. O'Grady JG, Gimson AES, O'Brien CJ et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure Gastroenterology 1988; 94 1186-92
51. Davenport A, Will EJ, Davidson AM Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328-38
52. Davenport A, Will EJ, Davidson AM et al. Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy Nephron 1989; 53: 142-6
53. Davenport A. Renal replacement therapy for patients with acute liver failure awaiting orthotopic hepatic transplantation. Nephron 1991; 59: 315-6
54. Lenz K, Hörtnagl H, Druml W et al. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor Gastroenterology 1991; 101: 1060-7
55. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990 b, 335: 1572-3
56. Keays R, Harrison PM, Wendon JA et al. Intravenous acetyl-cysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991, 303: 1026-9
57. Payne JA. Fulminant liver failure. Med Clin N Amer 1986; 70 1067-79
58. Quiroga J, Prieto J Liver cytoprotection by prostaglandins. Pharmac Ther 1993, 58: 67-92
59. 2 and rat liver regeneration. Gastroenterology 1993; 105: 495-9
60. 2) in the treatment of fulminant hepatic failure (FHF). Hepatology 1992; 16: 88A
61. Francavilla A, Azzarone A, Carrieri G et al Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure Hepatology 1993; 17. 429-33
62. Harrison PM, Hughes RD, Forbes A. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure J Hepatol 1990 a; 10: 332-6
63. Trey C, Burns DG, Saunders SJ Treatment of hepatic coma by exchange blood transfusion N Engl J Med 1966; 274: 473-81
64. Kondrup J, Almdal T, Vilstrup H, Tygstrup N. High volume plasma exchange in fulminant hepatic failure, Int J Artif Org 1992; 15: 669-76
65. De Groot GH, Schaim SW, Pick T et al. Strategies for hepatic support in acute liver failure, role of extracorporeal devices versus liver transplantation J Gastroenterol Hepatol 1989; 4. 283-93
66. Nyberg SL, Peshwa MV, Payne WD, Hu WS, Cerra FB. Evolution of the bioartificial liver: the need for randomized clinical trials. Amer J Surg 1993, 166. 512-21
67. Neuzil DF, Rozga J, Moscioni AD et al. Use of a novel bioartificial liver in a patient with acute liver insufficiency Surgery 1993; 113. 340-3
68. Chari RS, Collins BH, Magee JC et al. Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation N Engl J Med 1994; 331: 234-7
69. Sussman NL, Chong MG, Koussayer T et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device Hepatology 1992; 16: 60-5
70. Sussman NL, Gislason GT, Conlin CA, Kelly JH. Use of the hepatic extracorporeal liver assist device in the treatment of fulminant hepatic failure. Hepatology 1993; 18: 65A
71. Sussman NL, Finegold MJ, Barish JP, Kelly JH. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device Am J Gastroenterol 1994; 89: 1077-82
72. Moscioni AD, Row-Chowdhury J, Barbour R et al. Human liver cell transplantation: prolonged functon in athymic rats. Gastroenterology 1989; 96: 1546-51
73. Demetriou AA, Reisner A, Sanchez J et al. Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectromized rats. Hepatology 1988; 8: 1006-9
74. Fisher RA, Strom SC, Thompson MT et al. Human hepatocyte transplantation - a life bridge in terminal liver failure. Hepatology 1993, 18: 66A
75. Boudjema K, Jaeck D, Simeoni U et al. Temporary auxiliary liver transplantation for subacute liver failure in a child. Lancet 1993; 342: 778-9
76. O'Grady JG, Tan KC, Williams R. Selection criteria and results of orthotopic liver transplantation in the UK. In: Williams R, Hughes RD (eds.). Acute liver failure: improved understanding and better therapy. London: Miter Press, 1991: 77-80
77. Hughes RD, Wendon J, Gimson AES. Acute liver failure. Gut 1991; Suppl. S86-S91
78. Bernuau J, Samuel D, Durand F et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal, a prospective study Hepatology 1991; 14: 49A
79. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 4439-45
80. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria J Hepatol 1993; 17; 124-7
81. Takahashi Y, Kumada H, Shimizu M et al A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology 1994; 1065-71